Projects funded

REBONE
  • 2nd Joint Call – 2010

Hybrid Nanostructured Hydrogels: Bone regeneration using multifunctional injectable hydrogels

Summary (PDF)
Coordinator
José Domingos Silva Santos
Institution
Biosckin Molecular and Cell Therapies S.A.
Involved countries
  • ES
  • FR
  • PT
NanoSplice
  • 2nd Joint Call – 2010

Nanoconstructs for delivery of RNA splice-switching oligonucleotide therapeutics

Summary (PDF)
Coordinator
Edvard Smith
Institution
Karolinska Institutet, Department of Laboratory Medicine
Involved countries
  • LV
  • PL
  • SE
NanoGene
  • 2nd Joint Call – 2010

Stem cell generation and manipulation by nanoparticle mediated gene transfer for the safe clinical application of gene-modified cells

Summary (PDF)
Coordinator
Christine Günther
Institution
Apceth GmbH & CoKG
Involved countries
  • DE
  • ES
  • PT
NANODIATER
  • 2nd Joint Call – 2010

Nanoparticles designed to target chemokine-related inflammatory processes in vascular diseases and cancer metastasis and implementation of a biosensor to diagnose these disorders

Summary (PDF)
Coordinator
Maya Simionescu
Institution
Institute of Cellular Biology and Pathology “ N. Simionescu”
Involved countries
  • CH
  • DE
  • RO
  • TR
NANOASIT
  • 2nd Joint Call – 2010

Novel drug delivery routes mediated via nanotechnology; targeting allergy vaccination

Summary (PDF)
Coordinator
Håkan Engqvist
Institution
Uppsala University
Involved countries
  • CH
  • FR
  • SE
iNanoDCs
  • 2nd Joint Call – 2010

Design of multifunctional nanoparticles targeting TLR or Nod receptors for dendritic cell immune therapy

Summary (PDF)
Coordinator
Bernard Verrier
Institution
Centre National Recherche Scientifique
Involved countries
  • ES
  • FR
  • SE
HCVAX
  • 2nd Joint Call – 2010

Development of a Hepatitis C vaccine by targeted delivery of nanogel RNA-replicon constructs

Summary (PDF)
Coordinator
Ken McCullough
Institution
Institute of Virology and Immunoprophylaxis
Involved countries
  • CH
  • DE
  • FR
BIBA
  • 2nd Joint Call – 2010

Delivering nanopharmaceuticals through BIological Barriers

Summary (PDF)
Coordinator
Patrick Boisseau
Institution
CEA – Commissariat à l’énergie atomique
Involved countries
  • CH
  • DE
  • ES
  • FR